ESEA: Discovering the Dysregulated Pathways based on Edge Set Enrichment Analysis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Han, Junwei ^a   Shi, Xinrui ^a   Zhang, Yunpeng ^a   Xu, Yanjun ^a   Jiang, Ying ^b   Zhang, Chunlong ^a   Feng, Li ^a   Yang, Haixiu ^a   Shang, Desi ^a   Sun, Zeguo ^a   Su, Fei ^a   Li, Chunquan ^a   Li, Xia ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TP53 PROTEIN, HUMAN; TRANSCRIPTOME;

ALGORITHM; COLORECTAL TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; MOLECULAR GENETICS; RECEIVER OPERATING CHARACTERISTIC; SOFTWARE;

ALGORITHMS; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MOLECULAR SEQUENCE ANNOTATION; ROC CURVE; SOFTWARE; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84939459292     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13044     Document Type: Article

References (55)

1. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. & Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic acids research 40, D109-114 (2012).
2. Matthews, L. et al. Reactome knowledgebase of human biological pathways and processes. Nucleic acids research 37, D619-622 (2009).
3. Schaefer, C. F. et al. PID: The Pathway Interaction Database. Nucleic acids research 37, D674-679 (2009).
4. Khatri, P., Sirota, M. & Butte, A. J. Ten years of pathway analysis: Current approaches and outstanding challenges. PLoS Comput Biol 8, e1002375 (2012).
5. Mitrea, C. et al. Methods and approaches in the topology-based analysis of biological pathways. Front Physiol 4, 278 (2013).
6. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 4, 44-57 (2009).
7. Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102, 15545-15550 (2005).
8. Efron, B. & Tibshirani, R. On Testing the Significance of Sets of Genes. The Annals of Applied Statistics 1, 107-129 (2007).
9. Kim, S. Y. & Volsky, D. J. PAGE: Parametric analysis of gene set enrichment. BMC bioinformatics 6, 144 (2005).
10. Barry, W. T., Nobel, A. B. & Wright, F. A. Significance analysis of functional categories in gene expression studies: A structured permutation approach. Bioinformatics (Oxford, England) 21, 1943-1949 (2005).
11. Liu, Y., Koyuturk, M., Barnholtz-Sloan, J. S. & Chance, M. R. Gene interaction enrichment and network analysis to identify dysregulated pathways and their interactions in complex diseases. BMC systems biology 6, 65 (2012).
12. De La Fuente, A. From 'differential expression' to 'differential networking'-identification of dysfunctional regulatory networks in diseases. Trends Genet 26, 326-333 (2010).
13. Yu, H. et al. Link-based quantitative methods to identify differentially coexpressed genes and gene pairs. BMC bioinformatics 12, 315 (2011).
14. Kostka, D. & Spang, R. Finding disease specific alterations in the co-expression of genes. Bioinformatics (Oxford, England) 20 Suppl 1, i194-199 (2004).
15. Carter, S. L., Brechbuhler, C. M., Griffin, M. & Bond, A. T. Gene co-expression network topology provides a framework for molecular characterization of cellular state. Bioinformatics (Oxford, England) 20, 2242-2250 (2004).
16. Lai, Y., Wu, B., Chen, L. & Zhao, H. A statistical method for identifying differential gene-gene co-expression patterns. Bioinformatics (Oxford, England) 20, 3146-3155 (2004).
17. Zhang, J., Li, J. & Deng, H. W. Identifying gene interaction enrichment for gene expression data. PloS one 4, e8064 (2009).
18. Choi, Y. & Kendziorski, C. Statistical methods for gene set co-expression analysis. Bioinformatics (Oxford, England) 25, 2780-2786 (2009).
19. Rahnenfuhrer, J., Domingues, F. S., Maydt, J. & Lengauer, T. Calculating the statistical significance of changes in pathway activity from gene expression data. Stat Appl Genet Mol Biol 3, Article16 (2004).
20. Tarca, A. L. et al. A novel signaling pathway impact analysis. Bioinformatics (Oxford, England) 25, 75-82 (2009).
21. Hung, J. H. et al. Identification of functional modules that correlate with phenotypic difference: The influence of network topology. Genome biology 11, R23 (2010).
22. Paz, A. et al. SPIKE: A database of highly curated human signaling pathways. Nucleic acids research 39, D793-799 (2011).
23. Caspi, R. et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic acids research 42, D459-471 (2014).
24. Mi, H., Muruganujan, A. & Thomas, P. D. PANTHER in 2013: Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic acids research 41, D377-386 (2013).
25. Olivier, M. et al. The IARC TP53 database: New online mutation analysis and recommendations to users. Human mutation 19, 607-614 (2002).
26. Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature genetics 34, 267-273 (2003).
27. Su, L. J. et al. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap resampling scheme. BMC Genomics 8, 140 (2007).
28. Landi, M. T. et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PloS one 3, e1651 (2008).
29. Sales, G., Calura, E., Cavalieri, D. & Romualdi, C. graphite-a Bioconductor package to convert pathway topology to gene network. BMC bioinformatics 13, 20 (2012).
30. Margolin, A. A. et al. ARACNE: An algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC bioinformatics 7 Suppl 1, S7 (2006).
31. Mani, K. M. et al. A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas. Molecular systems biology 4, 169 (2008).
32. Sales, G. & Romualdi, C. parmigene-a parallel R package for mutual information estimation and gene network reconstruction. Bioinformatics (Oxford, England) 27, 1876-1877 (2011).
33. Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society, Series B (Methodological) 57 (1), 289-300 (1995).
34. Benavides, M. A. et al. Methionine inhibits cellular growth dependent on the p53 status of cells. Am J Surg 193, 274-283 (2007).
35. Ahrendt, S. A. et al. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Res 60, 3155-3159 (2000).
36. Xiong, S., Van Pelt, C. S., Elizondo-Fraire, A. C., Fernandez-Garcia, B. & Lozano, G. Loss of Mdm4 results in p53-dependent dilated cardiomyopathy. Circulation 115, 2925-2930 (2007).
37. Lukashev, M. E. & Werb, Z. ECM signalling: Orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8, 437-441 (1998).
38. Rodrigues, N. R. et al. p53 mutations in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 87, 7555-7559 (1990).
39. Stambolic, V. et al. Regulation of PTEN transcription by p53. Molecular cell 8, 317-325 (2001).
40. Pandurangan, A. K. Potential targets for prevention of colorectal cancer: A focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pac J Cancer Prev 14, 2201-2205 (2013).
41. Engelman, J. A. Targeting PI3K signalling in cancer: Opportunities, challenges and limitations. Nature reviews 9, 550-562 (2009).
42. Levina, E., Oren, M. & Ben-Ze'ev, A. Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics. Oncogene 23, 4444-4453 (2004).
43. Sadot, E., Geiger, B., Oren, M. & Ben-Ze'ev, A. Down-regulation of beta-catenin by activated p53. Molecular and cellular biology 21, 6768-6781 (2001).
44. Duursma, A. & Agami, R. p53-Dependent regulation of Cdc6 protein stability controls cellular proliferation. Molecular and cellular biology 25, 6937-6947 (2005).
45. Hemi, R. et al. Transactivation of ErbB2 and ErbB3 by tumor necrosis factor-alpha and anisomycin leads to impaired insulin signaling through serine/threonine phosphorylation of IRS proteins. The Journal of biological chemistry 277, 8961-8969 (2002).
46. Rao, Z. Opening up the group II chaperonins. Structure 18, 1221-1222 (2010).
47. Hoare, S. R. Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug discovery today 10, 417-427 (2005).
48. Pal, K., Melcher, K. & Xu, H. E. Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors. Acta pharmacologica Sinica 33, 300-311 (2012).
49. Andreasen, A. S., Kelly, M., Berg, R. M., Moller, K. & Pedersen, B. K. Type 2 diabetes is associated with altered NF-kappaB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS. PloS one 6, e23999 (2011).
50. Carlson, C. J., Koterski, S., Sciotti, R. J., Poccard, G. B. & Rondinone, C. M. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: Potential role of p38 in the downregulation of GLUT4 expression. Diabetes 52, 634-641 (2003).
51. Cao, Z., Wu, X., Yen, L., Sweeney, C. & Carraway, K. L., 3rd. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1. Molecular and cellular biology 27, 2180-2188 (2007).
52. Lau, E., Tsuji, T., Guo, L., Lu, S. H. & Jiang, W. The role of pre-replicative complex (pre-RC) components in oncogenesis. Faseb J 21, 3786-3794 (2007).
53. Zheng, Y. L. et al. Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: Genotype and phenotype analyses from a case-control study. International journal of cancer 126, 2199-2210 (2010).
54. Wolf, G. et al. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene 14, 543-549 (1997).
55. Dutta, B., Wallqvist, A. & Reifman, J. PathNet: A tool for pathway analysis using topological information. Source Code Biol Med 7, 10 (2012).